1041478

XGen Pharmaceuticals DJB, Inc. — FEI 3005548067

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Horseheads, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
2125521 CFR 329.100(c)(1)Failure to submit report in approved electronic format
673021 CFR 314.80(b)Failure to develop written procedures
683221 CFR 314.80(c)(2)Late submission of annual safety reports
684221 CFR 314.80(j)Failure to maintain records
891221 CFR 314.81(b)(2)Timely submission